Skip to content
thestock.space

On 6 Nov 2026, Chemcrux Enterprises was priced at ₹78.80, or 28.2× trailing earnings, against an industry P/E of 22.1×, and the shares are 15% below their 52-week high. Sales and net profit fell 9.4% and 36% a year over 3 years; its ROCE of 8.1% is the lowest among the 7 largest Specialty Chemicals peers. Debt is 0.43× equity, and its dividend yield is 1.3%. It is a small-cap company with a market cap of ₹117 Cr, ranked 146th of 204 Specialty Chemicals companies by market cap; the shares fell 9.4% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹79.12
Day high
₹80.35
Day low
₹77.54
Prev. close
₹79.12
Volume
9.6K

Health check

1 fair · 5 to check
  • ReturnsBehind

    −9.4% over a year, better than 0 of 7 peers.

  • Price tagPricier

    P/E 28.2 vs industry 22.1.

  • GrowthShrinking

    Sales −9.4%, profit −36.2% a year over 3 years.

  • ProfitabilityWeak

    ROCE 8.1% vs peer median 24.4%.

  • Balance sheetFair

    Debt 0.43× equity, interest covered 2.7×, Piotroski 6 of 9.

  • Red flags1 to check

    Return on equity is low at 5.9%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹117 Cr, #146 of 204 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹91 Cr · profit ₹4 Cr
Market cap
₹117 Cr
Small cap
P/E
28.2
Industry 22.1
Price to book
1.51
Peers 13.33
Dividend yield
1.27%
ROE
5.9%
Peers 23.0%
ROCE
8.1%
Peers 24.4%
Debt to equity
0.43
Debt ₹33 Cr
EPS (TTM)
₹2.79
Face value ₹10
OPM (TTM)
14.2%
Net margin 4.9%
Sales growth
+32.9%
Latest quarter vs a year ago
Profit growth
+445.0%
Latest quarter vs a year ago
Price to sales
1.28
EV/EBITDA 9.6

Strengths and risks

Strengths

  • Quarterly profit up 445.0% on a year ago.
  • Quarterly sales up 32.9% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Return on equity is low at 5.9%.

Derived automatically from reported figures. Not a recommendation.

About Chemcrux Enterprises

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid…

Headquarters
Vadodara
Employees
99
Sector
Basic Materials
ISIN
INE298W01016
Website
chemcrux.com

Price range

52 weeks

₹71.80₹92.91

Today

₹77.54₹80.35
Avg volume (3M)
5.4K
1-year return
minus 9.4%
From 52-week high
minus 15.2%

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%15.3%0.154.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.1%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
CHEMCRUXChemcrux Enterprises78.80minus 0.40%11728.211.98.1%14.2%0.43−9.4%minus 9.4%
Median of 7 peers–0.48%58,49670.944.424.4%24.1%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
16.517.722.124.321.9
14.91618.620.119.2
1.61.83.54.22.7
9.8%10.1%16.0%17.2%12.3%
0.40.60.60.40.1
0.90.80.80.70.6
1.21.21.21.21.2
00.42.22.71
−199.7%46.3%27.9%30.7%48.5%
0.10.21.61.80.5
0.060.141.061.250.34

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−9.4%
Profit CAGR 3Y
−36.2%
EPS CAGR 3Y
−36.2%
ROE
5.9%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
80.857.357.660.1
–minus 29.0%+0.5%+4.2%
59.343.848.448.9
21.513.59.211.2
26.6%23.5%16.0%18.6%
0.50.91.20.8
0.60.71.73.1
22.33.24.7
0.40.10.31.1
19.611.45.85.3
26.9%26.1%32.1%29.4%
14.48.43.93.7
–minus 41.2%minus 53.7%minus 4.7%
9.705.702.642.52

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
14.814.814.814.8
51.657.459.862
14.426.542.334.4
12.411.210.116.2
93.2110127127
32.753.577.978.2
0.321.11.64.1
––20
23.724.820.818.3
36.510.524.826.8
93.2110127127

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
14.816.37.613.9
−20.5−25.9−6−0.1
17.6−5.7−12.4
−4.7−1.9−41.4
−11.2−24.3−8.4−5.1
3.7−7.9−0.88.7
−3−3−1.5−1.5

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company.

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you